Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response
暂无分享,去创建一个
G. Ingravallo | C. Simone | S. Murzilli | A. Del Rio | N. Martelli | V. Grossi | A. Napoli | M. Liuzzi